Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$677K Sell
5,587
-60
-1% -$6.93K 0.54% 46
2025
Q4
$600K Sell
5,647
-200
-3% -$18.8K 0.48% 48
2025
Q3
$491K Sell
5,847
-160
-3% -$13.2K 0.39% 53
2025
Q2
$476K Sell
6,007
-86
-1% -$6.84K 0.41% 53
2025
Q1
$547K Buy
6,093
+30
+0.5% +$2.8K 0.51% 50
2024
Q4
$603K Buy
+6,063
New +$625K 0.53% 46

Other funds holding MRK

PCG Asset Management's MRK Position: Q1 2026 in Review

PCG Asset Management reduced its Merck (MRK) stake by 1.1% in Q1 2026, selling an estimated $6.93K and leaving 5,587 shares worth $677K. The position accounts for 0.54% of the portfolio, ranked #46.

PCG Asset Management first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • PCG Asset Management held 5,587 shares of Merck worth $677K as of Q1 2026.
  • PCG Asset Management sold 60 Merck shares in Q1 2026, an estimated $6.93K.
  • Merck made up 0.54% of PCG Asset Management's portfolio in Q1 2026, its #46 holding.
  • PCG Asset Management first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on PCG Asset Management's 13F filing for Q1 2026, filed 12 May 2026.